High-Resolution CT Thorax and Serum IL-6 Levels in Patients with  Interstitial Lung Disease

Beenish Javaid, Naeem Ahmad Khan, Fatima Iqbal, Nazish Khalid, Anam Shafique, Noman Johnson

High-Resolution CT Thorax and Serum IL-6 Levels in Patients with Interstitial Lung Disease

Authors

Beenish Javaid, Naeem Ahmad Khan, Fatima Iqbal, Nazish Khalid, Anam Shafique, Noman Johnson

Keywords:

interstitial lung disease, HRCT, IL-6, pulmonary fibrosis, biomarker.

Abstract

Background: Interstitial lung diseases (ILDs) represent a diverse group of chronic lung disorderscharacterized by inflammation, fibrosis, and impaired gas exchange. High-resolution computedtomography (HRCT) is considered the imaging gold standard for diagnosis andcharacterizationof ILDs. Meanwhile, interleukin-6 (IL-6), a pro-inflammatory cytokine, has emerged as a potentialbiomarker.

References

Raghu G, et al. Diagnosis of ILDs: ATS/ERS guidelines. Am J Respir Crit Care Med. 2018;198(5):e44–e68.

Jacob J, et al. HRCT in ILD diagnosis and prognostication. Eur Respir J. 2021;57(1):2001538.

Downloads

Published

2025-08-30

How to Cite

Beenish Javaid, Naeem Ahmad Khan, Fatima Iqbal, Nazish Khalid, Anam Shafique, Noman Johnson. (2025). High-Resolution CT Thorax and Serum IL-6 Levels in Patients with Interstitial Lung Disease. International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 1714–1720. Retrieved from https://www.ijprt.org/index.php/pub/article/view/954